TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy
Authors
Keywords
PCNSL, <em class=EmphasisTypeItalic >TP53</em>, <em class=EmphasisTypeItalic >MIR34A</em>, Hotspot mutations, DNA methylation, Survival
Journal
Acta Neuropathologica Communications
Volume 4, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-04-22
DOI
10.1186/s40478-016-0307-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TP53: an oncogene in disguise
- (2015) T Soussi et al. CELL DEATH AND DIFFERENTIATION
- Diffuse large B-cell lymphoma with combined TP53 mutation and MIR34A methylation: Another “double hit” lymphoma with very poor outcome?
- (2015) Fazila Asmar et al. Oncotarget
- Hypermethylation of DAPK1 is an independent prognostic factor predicting survival in diffuse large B-cell lymphoma
- (2015) Lasse Sommer Kristensen et al. Oncotarget
- Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue
- (2014) D. W. Scott et al. BLOOD
- Locus-Specific Databases in Cancer: What Future in a Post-Genomic Era? The TP53 LSDB paradigm
- (2014) Thierry Soussi HUMAN MUTATION
- TP53 Mutations in Human Cancer: Database Reassessment and Prospects for the Next Decade
- (2014) Bernard Leroy et al. HUMAN MUTATION
- Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphoma
- (2014) Adam J. Olszewski et al. LEUKEMIA RESEARCH
- Reporting Tumor Molecular Heterogeneity in Histopathological Diagnosis
- (2014) Andrea Mafficini et al. PLoS One
- Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing
- (2013) R. D. Morin et al. BLOOD
- Ten Years of International Primary CNS Lymphoma Collaborative Group Studies
- (2013) Andrés J.M. Ferreri et al. JOURNAL OF CLINICAL ONCOLOGY
- Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202)
- (2013) James L. Rubenstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Investigation of MGMT and DAPK1 methylation patterns in diffuse large B-cell lymphoma using allelic MSP-pyrosequencing
- (2013) Lasse Sommer Kristensen et al. Scientific Reports
- Characterizing and measuring bias in sequence data
- (2013) Michael G Ross et al. GENOME BIOLOGY
- Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies
- (2012) Z. Y. Xu-Monette et al. BLOOD
- Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
- (2012) Z. Y. Xu-Monette et al. BLOOD
- Immunologic Privilege in the Central Nervous System and the Blood–Brain Barrier
- (2012) Leslie L Muldoon et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
- (2012) Tina Marie Green et al. JOURNAL OF CLINICAL ONCOLOGY
- Data-driven unbiased curation of the TP53 tumor suppressor gene mutation database and validation by ultradeep sequencing of human tumors
- (2012) K. Edlund et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Association of a MicroRNA/TP53 Feedback Circuitry With Pathogenesis and Outcome of B-Cell Chronic Lymphocytic Leukemia
- (2011) Muller Fabbri JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- O 6-methylguanine-DNA methyltransferase promoter methylation in 45 primary central nervous system lymphomas: quantitative assessment of methylation and response to temozolomide treatment
- (2011) Jun-ichi Adachi et al. JOURNAL OF NEURO-ONCOLOGY
- CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group
- (2011) Michael Pfreundschuh et al. LANCET ONCOLOGY
- Negative regulation of the tumor suppressor p53 gene by microRNAs
- (2010) M Kumar et al. ONCOGENE
- Mutant p53 Gain-of-Function in Cancer
- (2009) M. Oren et al. Cold Spring Harbor Perspectives in Biology
- Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study
- (2008) K. H. Young et al. BLOOD
- Epigenetic Silencing of MicroRNA-34b/c and B-Cell Translocation Gene 4 Is Associated with CpG Island Methylation in Colorectal Cancer
- (2008) M. Toyota et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now